US Patent Issued to Shanghai AbelZeta on July 7 for "Anti-BCMA antibodies and chimeric antigen receptors" (Chinese, American Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,071, issued on July 7, was assigned to Shanghai AbelZeta Ltd. (Shanghai).

"Anti-BCMA antibodies and chimeric antigen receptors" was invented by Jiaqi Huang (Rockville, Md.), Yihong Yao (Rockville, Md.), Shigui Zhu (Rockville, Md.), Xin Yao (Rockville, Md.), Yun Ji (Shanghai), Wei Xue (Shanghai), Yutian Wei (Shanghai), Cheng Chen (Shanghai) and Chaocan Zhang (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Anti-BCMA antibodies and chimeric antigen receptors (CARs) are provided. Immune cells expressing the anti-BCMA CAR can be used to treat cancer. The anti-BCMA antibodies and CARs can recognize the extracellular domains of human BCMA. The anti...